Condition: I) Atypical Squamous Cells of Undetermined Significance (ASC-US) · II) Atypical Glandular Cells of Uncertain Significance (AGUS) · III) Cervical Intraepithelial Neoplasia (CIN), CIN-1, CIN-2, CIN-3 · Sponsor: Timser SAPI de CV
This study compares how effective is the molecular screening (a blood test) using Pap smear as reference, that is, a comparison of these tests abilities to detect precursor lesions and cervical cancer among women of an open population
This description comes directly from the study's public registry record.
Mercedes Gutiérrez-Smith, Bachelor of Arts in History · +52-55-9057-1000 · mercedes@atsopharma.com
Fátima R Ruiz-Rosales, Bachelor of Medicine · +52-56-3953-3339 · medico@preventix.mx
Always discuss trial participation with your own doctor first.
| Consultorio Médico TIMSER | Mexico City, Mexico City, Mexico | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07480902